Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Aurobindo Pharma Limited

NDC labeler codes: 59651, 65862, 84386

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

1,035Products (NDC)

Prescription medicines

Show the other 289 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
October 2, 2026ANDA220492 Perampanel
PERAMPANEL
Aurobindo Pharma Ltd
September 25, 2026ANDA218485 Metronidazole
METRONIDAZOLE
Aurobindo Pharma Ltd
September 17, 2026ANDA219652 Cyclosporine
CYCLOSPORINE
Aurobindo Pharma Ltd
September 10, 2026ANDA220336 Isotretinoin
ISOTRETINOIN
Aurobindo Pharma Ltd
September 2, 2026ANDA213631 Sacubitril and valsartan
SACUBITRIL AND VALSARTAN
Aurobindo Pharma Ltd
August 10, 2026ANDA220288 Brivaracetam
BRIVARACETAM
Aurobindo Pharma
August 5, 2026ANDA216481 Eslicarbazepine acetate
ESLICARBAZEPINE ACETATE
Aurobindo Pharma
July 22, 2026ANDA217384 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Aurobindo Pharma Ltd
July 21, 2026ANDA216051 Bupropion
BUPROPION HYDROCHLORIDE
Aurobindo Pharma Ltd
July 15, 2026ANDA214872 Etodolac
ETODOLAC
Aurobindo Pharma Ltd
June 24, 2026ANDA218949 Icosapent ethyl
ICOSAPENT ETHYL
Aurobindo Pharma Ltd
June 9, 2026ANDA213568 Cephalexin
CEPHALEXIN
Aurobindo Pharma
June 3, 2026ANDA215356 Tofacitinib
TOFACITINIB CITRATE
Aurobindo Pharma Ltd
April 20, 2026ANDA212597 Pirfenidone
PIRFENIDONE
Aurobindo Pharma
April 15, 2026ANDA220313 Glycerol phenylbutyrate
GLYCEROL PHENYLBUTYRATE
Aurobindo Pharma
April 6, 2026ANDA211468 Dapagliflozin
DAPAGLIFLOZIN
Aurobindo Pharma
April 6, 2026ANDA211489 Dapagliflozin and metformin hydrochloride
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Aurobindo Pharma
March 23, 2026ANDA217607 Cefixime
CEFIXIME
Aurobindo Pharma Ltd
March 18, 2026ANDA218942 Clindamycin
CLINDAMYCIN PHOSPHATE
Aurobindo Pharma Ltd
March 13, 2026ANDA219985 Citalopram
CITALOPRAM HYDROBROMIDE
Aurobindo Pharma Ltd
February 25, 2026ANDA219533 Everolimus
EVEROLIMUS
Eugia Pharma
February 18, 2026ANDA216208 Aripiprazole
ARIPIPRAZOLE
Aurobindo Pharma
January 26, 2026ANDA219348 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Aurobindo Pharma Ltd
January 21, 2026ANDA217922 Bisoprolol fumarate and hydrochlorothiazide
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Aurobindo Pharma Ltd
November 20, 2025ANDA216536 Potassium chloride
POTASSIUM CHLORIDE
Aurobindo Pharma
Show the other 100 applications
ApprovedApplicationMedicineSponsor
November 14, 2025ANDA217608 Fosfomycin
FOSFOMYCIN TROMETHAMINE
Aurobindo Pharma Ltd
October 3, 2025ANDA216504 Naproxen
NAPROXEN
Aurobindo Pharma
September 8, 2025ANDA215137 Deferasirox
DEFERASIROX
Aurobindo Pharma
September 8, 2025ANDA218734 Prochlorperazine
PROCHLORPERAZINE MALEATE
Aurobindo Pharma Ltd
August 11, 2025ANDA212596 Pirfenidone
PIRFENIDONE
Aurobindo Pharma
July 29, 2025ANDA219759 Lidocaine
LIDOCAINE HYDROCHLORIDE
Aurobindo Pharma Ltd
July 17, 2025ANDA218831 Furosemide
FUROSEMIDE
Aurobindo Pharma Ltd
July 9, 2025ANDA219091 Famotidine
FAMOTIDINE
Aurobindo Pharma Ltd
July 9, 2025ANDA219295 Metronidazole
METRONIDAZOLE
Aurobindo Pharma Ltd
June 30, 2025ANDA219538 Ibuprofen and famotidine
IBUPROFEN AND FAMOTIDINE
Aurobindo Pharma Ltd
June 9, 2025ANDA216797 Sapropterin dihydrochloride
SAPROPTERIN DIHYDROCHLORIDE
Aurobindo Pharma
May 30, 2025ANDA212089 Acetazolamide
ACETAZOLAMIDE
Aurobindo Pharma Ltd
May 14, 2025ANDA208039 Dabigatran etexilate
DABIGATRAN ETEXILATE MESYLATE
Aurobindo Pharma
May 2, 2025ANDA214595 Varenicline tartrate
VARENICLINE TARTRATE
Aurobindo Pharma
April 30, 2025ANDA219241 Oxcarbazepine
OXCARBAZEPINE
Aurobindo Pharma Ltd
April 25, 2025ANDA216788 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE
Aurobindo Pharma Ltd
April 22, 2025ANDA216547 Dasatinib
DASATINIB
Eugia Pharma
April 15, 2025ANDA218948 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Aurobindo Pharma Ltd
April 15, 2025ANDA219213 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Aurobindo Pharma Ltd
April 14, 2025ANDA215091 Allopurinol
ALLOPURINOL
Aurobindo Pharma Ltd
April 10, 2025ANDA208544 Rivaroxaban
RIVAROXABAN
Aurobindo Pharma Ltd
April 4, 2025ANDA218457 Dapsone
DAPSONE
Aurobindo Pharma Ltd
March 31, 2025ANDA217923 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Aurobindo Pharma Ltd
March 21, 2025ANDA219527 Nystatin
NYSTATIN
Aurobindo Pharma
February 27, 2025ANDA218245 Tretinoin
TRETINOIN
Aurobindo Pharma Ltd
January 13, 2025ANDA218246 Tretinoin
TRETINOIN
Aurobindo Pharma Ltd
December 31, 2024ANDA214847 Glycopyrrolate
GLYCOPYRROLATE
Aurobindo Pharma Ltd
December 12, 2024ANDA212923 Clozapine
CLOZAPINE
Aurobindo Pharma
December 4, 2024ANDA219034 Pazopanib
PAZOPANIB HYDROCHLORIDE
Eugia Pharma
November 12, 2024ANDA218997 Cimetidine
CIMETIDINE
Aurobindo Pharma Ltd
October 18, 2024ANDA209694 Metformin hydrochloride
METFORMIN HYDROCHLORIDE
Aurobindo Pharma
October 15, 2024ANDA218941 Metronidazole
METRONIDAZOLE
Aurobindo Pharma Ltd
September 27, 2024ANDA218817 Cephalexin
CEPHALEXIN
Aurobindo Pharma Ltd
September 26, 2024ANDA218227 Mycophenolate mofetil
MYCOPHENOLATE MOFETIL
Aurobindo Pharma Ltd
August 2, 2024ANDA216550 Estradiol
ESTRADIOL
Aurobindo Pharma
July 25, 2024ANDA216041 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Aurobindo Pharma Ltd
July 18, 2024ANDA213300 Dutasteride and tamsulosin hydrochloride
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Aurobindo Pharma
July 18, 2024ANDA217119 Posaconazole
POSACONAZOLE
Aurobindo Pharma
July 16, 2024ANDA216414 Levothyroxine
LEVOTHYROXINE SODIUM
Aurobindo Pharma
June 18, 2024ANDA217117 Lidocaine
LIDOCAINE
Aurobindo Pharma Ltd
June 3, 2024ANDA218462 Tofacitinib
TOFACITINIB CITRATE
Aurobindo Pharma Ltd
May 10, 2024ANDA218131 Oseltamivir phosphate
OSELTAMIVIR PHOSPHATE
Aurobindo Pharma Ltd
April 29, 2024ANDA215463 Colchicine
COLCHICINE
Aurobindo Pharma Ltd
April 19, 2024ANDA218789 Haloperidol
HALOPERIDOL
Aurobindo Pharma Ltd
April 10, 2024ANDA218289 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Aurobindo Pharma Ltd
March 21, 2024ANDA213095 Desmopressin acetate
DESMOPRESSIN ACETATE
Aurobindo Pharma
March 18, 2024ANDA215878 Mometasone furoate monohydrate
MOMETASONE FUROATE
Aurobindo Pharma
March 14, 2024ANDA218615 Sunitinib malate
SUNITINIB MALATE
Eugia Pharma
February 28, 2024ANDA207983 Fingolimod
FINGOLIMOD HYDROCHLORIDE
Aurobindo Pharma Ltd
February 27, 2024ANDA218603 Mycophenolic acid
MYCOPHENOLATE SODIUM
Aurobindo Pharma Ltd
February 20, 2024ANDA217937 Mycophenolate mofetil
MYCOPHENOLATE MOFETIL
Aurobindo Pharma
February 13, 2024ANDA217118 Atorvastatin
ATORVASTATIN CALCIUM
Aurobindo Pharma Ltd
February 9, 2024ANDA217123 Deflazacort
DEFLAZACORT
Aurobindo Pharma Ltd
January 29, 2024ANDA218194 Isotretinoin
ISOTRETINOIN
Aurobindo Pharma
January 24, 2024ANDA209224 Lacosamide
LACOSAMIDE
Aurobindo Pharma Ltd
January 8, 2024ANDA216458 Enalapril maleate
ENALAPRIL MALEATE
Aurobindo Pharma
January 5, 2024ANDA217828 Mycophenolate mofetil
MYCOPHENOLATE MOFETIL
Aurobindo Pharma Ltd
December 14, 2023ANDA217843 Diazepam
DIAZEPAM
Aurobindo Pharma Ltd
November 29, 2023ANDA216667 Budesonide
BUDESONIDE
Eugia Pharma
November 28, 2023ANDA210677 Darunavir
DARUNAVIR
Aurobindo Pharma Ltd
November 27, 2023ANDA213163 Zafirlukast
ZAFIRLUKAST
Aurobindo Pharma
November 7, 2023ANDA215063 Lifitegrast
LIFITEGRAST
Eugia Pharma
October 31, 2023ANDA216554 Ampicillin
AMPICILLIN TRIHYDRATE
Aurobindo Pharma
October 26, 2023ANDA217879 Nitroglycerin
NITROGLYCERIN
Aurobindo Pharma
October 25, 2023ANDA210741 Febuxostat
FEBUXOSTAT
Aurobindo Pharma Ltd
October 16, 2023ANDA214474 Deferasirox
DEFERASIROX
Aurobindo Pharma Ltd
September 27, 2023ANDA215449 Topiramate
TOPIRAMATE
Aurobindo Pharma Ltd
September 14, 2023ANDA216419 Chlordiazepoxide hydrochloride and clidinium bromide
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Aurobindo Pharma Ltd
September 5, 2023ANDA218122 Loperamide hydrochloride
LOPERAMIDE HYDROCHLORIDE
Aurobindo Pharma Ltd
August 18, 2023ANDA218055 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE
Aurobindo Pharma Ltd
July 31, 2023ANDA205972 Saxagliptin
SAXAGLIPTIN
Aurobindo Pharma
July 17, 2023ANDA214649 Hydrocortisone
HYDROCORTISONE
Aurobindo Pharma Ltd
July 11, 2023ANDA212599 Sevelamer hydrochloride
SEVELAMER HYDROCHLORIDE
Aurobindo Pharma Ltd
July 10, 2023ANDA215972 Ramelteon
RAMELTEON
Aurobindo Pharma Ltd
June 30, 2023ANDA214729 Estradiol and norethindrone acetate
ETYQA
Aurobindo Pharma Ltd
June 16, 2023ANDA217230 Rufinamide
RUFINAMIDE
Aurobindo Pharma
May 11, 2023ANDA212607 Nitrofurantoin
NITROFURANTOIN
Aurobindo Pharma
May 8, 2023ANDA215600 Phenoxybenzamine hydrochloride
PHENOXYBENZAMINE HYDROCHLORIDE
Aurobindo Pharma
April 18, 2023ANDA211198 Macitentan
MACITENTAN
Aurobindo Pharma Ltd
April 18, 2023ANDA215056 Cevimeline hydrochloride
CEVIMELINE HYDROCHLORIDE
Aurobindo Pharma
April 17, 2023ANDA213298 Roflumilast
ROFLUMILAST
Aurobindo Pharma Ltd
March 31, 2023ANDA213052 Prazosin hydrochloride
PRAZOSIN HYDROCHLORIDE
Aurobindo Pharma Ltd
March 31, 2023ANDA214477 Mesalamine
MESALAMINE
Aurobindo Pharma Ltd
March 30, 2023ANDA209225 Nitrofurantoin (monohydrate/macrocrystals)
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Aurobindo Pharma
March 29, 2023ANDA205321 Pregabalin
PREGABALIN
Aurobindo Pharma
March 28, 2023ANDA207167 Lansoprazole
LANSOPRAZOLE
Aurobindo Pharma Ltd
March 23, 2023ANDA213540 Timolol
TIMOLOL MALEATE
Eugia Pharma
March 20, 2023ANDA216440 Clomipramine hydrochloride
CLOMIPRAMINE HYDROCHLORIDE
Aurobindo Pharma
March 17, 2023ANDA215673 Prednisolone
PREDNISOLONE
Aurobindo Pharma Ltd
March 15, 2023ANDA079188 Emtricitabine
EMTRICITABINE
Aurobindo Pharma Ltd
March 10, 2023ANDA208045 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE
Aurobindo Pharma Ltd
March 9, 2023ANDA211640 Emtricitabine and tenofovir disoproxil fumarate
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Aurobindo Pharma Ltd
March 6, 2023ANDA213885 Lenalidomide
LENALIDOMIDE
Eugia Pharma
February 21, 2023ANDA213096 Propafenone hydrochloride
PROPAFENONE HYDROCHLORIDE
Aurobindo Pharma Ltd
January 6, 2023ANDA214848 Brivaracetam
BRIVARACETAM
Aurobindo Pharma Ltd
January 6, 2023ANDA216796 Norethindrone
EMZAHH
Aurobindo Pharma
January 5, 2023ANDA204994 Lacosamide
LACOSAMIDE
Aurobindo Pharma Ltd
December 27, 2022ANDA206817 Solifenacin succinate
SOLIFENACIN SUCCINATE
Aurobindo Pharma
December 23, 2022ANDA209081 Ranolazine
RANOLAZINE
Aurobindo Pharma
December 23, 2022ANDA214773 Sildenafil
SILDENAFIL CITRATE
Aurobindo Pharma Ltd

Showing the 125 newest of 446 applications. Full lists: Drugs@FDA →

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. July 23, 2026 · Class II · Ongoing · D-0733-2026 · Dicyclomine hydrochloride

    shortfill; reports of empty capsules.

    Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

2024

  1. December 6, 2024 · Class II · Ongoing · D-0149-2025 · Nebivolol

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

    Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. NDC: 59651-137-30

2023

  1. July 21, 2023 · Class II · Terminated · D-1087-2023 · Rufinamide

    cGMP deviations: Batch was released prior to approval.

    Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-616-08

  2. July 21, 2023 · Class II · Terminated · D-1088-2023 · Rufinamide

    cGMP deviations: Batch was released prior to approval.

    Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-617-08

2022

  1. October 5, 2022 · Class II · Completed · D-0021-2023 · Quinapril HCL and hydrochlorothiazide

    CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

    Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-162-90

  2. April 13, 2022 · Class II · Terminated · D-1103-2022 · Ondansetron

    cGMP deviations: Temperature abuse

    Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30

  3. January 14, 2022 · Class II · Terminated · D-0560-2022 · Moxifloxacin

    Failed Impurities/Degradation Specifications

    Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

2021

  1. November 15, 2021 · Class III · Terminated · D-0263-2022 · Carvedilol

    Failed Impurities/Degradation Specifications

    Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by: Aurobindo Pharma USA Inc., 279 Princeton-Hightstown Road, East Windsor, NJ, 08520, Made in India, NDC 65862-143-05

  2. September 9, 2021 · Class II · Terminated · D-0812-2021 · Metoprolol

    Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

    Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99

  3. July 7, 2021 · Class II · Terminated · D-0719-2021 · Sulfamethoxazole and trimethoprim

    Presence of Foreign Substance- Potential of metal contamination.

    Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HIghtstown Road, EAs Windsor, NJ 08520, Made in India, NDC 65862

Show the 30 older recalls

2021

  1. March 15, 2021 · Class II · Terminated · D-0438-2021 · Eletriptan hydrobromide

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Eletriptan Hydrobromide Tablets 20 mg* 6(1x6) Unit-dose Tablets Rx only NDC 59651-104-69 Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520

  2. March 15, 2021 · Class II · Terminated · D-0437-2021 · Ibuprofen

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    IBUPROFEN ORAL SUSPENSION USP 100MG/5ML 120ML ; NDC/UPC 59651-032-12; RX; SUSPENSION (NO DROPS)

  3. January 20, 2021 · Class II · Terminated · D-0290-2021 · Famotidine

    Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

    Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99

2020

  1. August 10, 2020 · Class II · Terminated · D-1535-2020 · Sulfamethoxazole and trimethoprim

    Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).

    Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in In

  2. June 12, 2020 · Class II · Terminated · D-1370-2020 · Clozapine

    Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

    Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05

  3. March 18, 2020 · Class II · Terminated · D-1233-2020 · Levetiracetam

    CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

    Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08

  4. March 18, 2020 · Class II · Terminated · D-1232-2020 · Gabapentin

    CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

    Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99

  5. March 18, 2020 · Class II · Terminated · D-1234-2020 · Simvastatin

    CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

    Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90

  6. February 7, 2020 · Class II · Terminated · D-0852-2020 · Amoxicillin and clavulanate potassium (amoxicillin / clavulanate)

    Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie

    Amoxicillin and Clavulanate Potassium Tablets, USP, 875 mg/125 mg, 20-count bottles, Distributed by: Aurobindo Pharma USA. Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India; NDC 65862-503-20

2019

  1. December 2, 2019 · Class III · Terminated · D-0789-2020 · Moxifloxacin

    Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.

    Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.

  2. July 29, 2019 · Class III · Terminated · D-1842-2019 · Simvastatin

    Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B

    Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99

2018

  1. December 31, 2018 · Class II · Ongoing · D-1038-2019 · Valsartan

    GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

    Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90

  2. December 31, 2018 · Class II · Ongoing · D-0370-2019 · Valsartan

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.

  3. December 31, 2018 · Class II · Ongoing · D-1039-2019 · Valsartan

    GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

    Valsartan Tablets USP 160 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-572-90

  4. December 31, 2018 · Class II · Ongoing · D-1037-2019 · Valsartan

    GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

    Valsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-570-30

  5. December 31, 2018 · Class II · Ongoing · D-1035-2019 · Valsartan

    GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

    Valsartan Tablets USP 320 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-573-90

  6. December 31, 2018 · Class II · Ongoing · D-0366-2019 · Valsartan and hydrochlorothiazide

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-548-90.

  7. December 31, 2018 · Class II · Ongoing · D-0364-2019 · Amlodipine and valsartan

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-740-30.

  8. December 31, 2018 · Class II · Ongoing · D-0368-2019 · Valsartan and hydrochlorothiazide

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-547-90.

  9. December 31, 2018 · Class II · Ongoing · D-1036-2019 · Amlodipine and valsartan

    GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

    Amlodipine and Valsartan Tablets USP 10mg/160mg, 30 count bottles, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ Manufactured by: Aurobindo Pharma Limited, India --- NDC 65862-739-30

  10. December 31, 2018 · Class II · Ongoing · D-0362-2019 · Amlodipine and valsartan

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Amlodipine and Valsartan Tablets USP 10 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-739-30.

  11. December 31, 2018 · Class II · Ongoing · D-0361-2019 · Amlodipine and valsartan

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-737-30

  12. December 31, 2018 · Class II · Ongoing · D-0365-2019 · Valsartan and hydrochlorothiazide

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-550-90.

  13. December 31, 2018 · Class II · Ongoing · D-0369-2019 · Valsartan and hydrochlorothiazide

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-549-90.

  14. December 31, 2018 · Class II · Ongoing · D-0363-2019 · Amlodipine and valsartan

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Amlodipine and Valsartan Tablets USP 5 mg/320 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-738-30.

  15. December 31, 2018 · Class II · Ongoing · D-0367-2019 · Valsartan and hydrochlorothiazide

    CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

    Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-551-90.

  16. November 30, 2018 · Class III · Terminated · D-0289-2019 · Amlodipine and olmesartan medoxomil

    Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).

    Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30

  17. February 2, 2018 · Class III · Terminated · D-0427-2018 · Metformin hydrochloride

    Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg

    Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit -VII (SEZ)) Mah

2016

  1. December 22, 2016 · Class II · Terminated · D-0474-2017 · Venlafaxine hydrochloride

    Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.

    Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyder

2013

  1. April 9, 2013 · Class III · Terminated · D-498-2013 · Lisinopril

    Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

    Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →